Supplemental Figure 1.
Fluorescence spectra analysis to confirm the conformational change of the BCL2 i-motif produced by IMC-76 and IMC48. (A) pH-dependent FRET changes in the BCL2 i-motif labeled with FAM at the 5´-end and TAMRA at the 3´-end of the oligomer. At low pH (pH 6.3), the I 580 /I 520 ratio is 7.45, showing a closer distance between two dyes by folding the i-motif, while at high pH (pH 6.6) the I 580 /I 520 ratio is 1.45, showing a longer distance between two dyes by unfolding the i-motif. (B) Dose-dependent spectra change by IMC-76 at pH 6.3, I 520 . (C) Dose-dependent spectra change by IMC-48 at pH6.6, I 580 . Insets in (B) and (C) show a graph of the dose response from the spectral analysis at I 580 . A PTI fluorometer was used to measure the spectra. Figure 2 . CD spectra of the BCL2 i-motif with IMC-48 and IMC-76. IMC-48 and IMC-76 were incubated with the DNA at 50 mM Na cacodylate buffer (pH 6.6 and pH 6.3, respectively). The ellipticity at 286 nm was monitored with 1 °C/min of temperature increase for melting analysis, and then sigmoidal curve fitting was used to calculate T m . DMSO was treated as a control. Figure 3 . CD spectral and thermal stability analyses of capping mutants. (A) Folding pattern of the BCL-2 i-motif with the capping structure nucleotides labeled. (B) CD spectra of the BCL-2 i-motif capping mutants C22, C23, T20, T21, and T24 in comparison to the wild-type sequence. Supplemental Table 1 . Sequences of BCL2 FRET and NdU probes. -OCOCH 3 -COCH 2 OCOCH 3 -OH 181.0 Analysis of structure and FRET values: IMC-76 was identified from the NCI Diversity Set and shows a FRET value of 270. It is a steroidal molecule predominantly substituted on ring D at C17. Screening of similar steroidal molecules from the ChemDiv collection resulted in identification of compounds that exert a similar effect on FRET: an increase indicating destabilization of the BCL2 i-motif. Although definite conclusions cannot be drawn about structure-activity relationships (SAR), activity trend was observed for steroidal compounds with C17 substitution. A detailed SAR would require design, synthesis, and testing of analogs; hence this would be a part of future studies on these compounds.
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DNA Probe Sequence (5´ → → → → 3´) BCL2 i-motif for HTS FAM-CAGCCCCGCTCCCGCCCCCTTCCTCCCGCGCCCGCCCCT- BHQ BCL2 i-motif FAM-CAGCCCCGCTCCCGCCCCCTTCCTCCCGCGCCCGCCCCT- TAMRA BCL2 i-motif mutant FAM -CAGTTTTGCTCCCGCTTTCTTCCTTTTGCGCCCGCCCCT- TAMRA BCL2 G-quadruplex FAM-AGGGGCGGGCGCGGGAGGAAGGGGGCGGGAGCGGGGCTG- TAMRA c-MYC i-motif FAM-TCCCCACCTTCCCCACCCTCCCCACCCTCCCCA-TAMRA VEGF i-motif FAM-CTCCGCCCCGCCGGGACCCCGCCCCCGGCCCGCCCC-TAMRA 20T CAGCCCCGCTCCCGCCCCCNdUTCCTCCCGCGCCCGCCCCT 21T CAGCCCCGCTCCCGCCCCCTNdUCCTCCCGCGCCCGCCCCT 24T CAGCCCCGCTCCCGCCCCCTTCCNdUCCCGCGCCCGCCCCT 39T CAGCCCCGCTCCCGCCCCCTTCCTCCCGCGCCCGCCCCNdU S11 Supplemental
